Better treatment of outpatients with type 1 diabetes after introduction of continuous subcutaneous insulin infusion

Danish Medical Journal

Volumn 59, Issue 6, 2012, Pages

  Marmolin, Ea Sofie ^a   Brødsgaard, Jane ^a   Gjessing, Hans Jørgen ^a   Schousboe, Karoline ^a   Grodum, Ellen ^a   Jørgensen, Ulla Linding ^a   Møller, Charlotte Chrois ^a   Pedersen, Jette ^a  

^a Fredericia Sygehus   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGED; ARTICLE; CONTINUOUS INFUSION; DIABETIC KETOACIDOSIS; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OUTPATIENT DEPARTMENT; PATIENT SATISFACTION; QUESTIONNAIRE; SCORING SYSTEM; TREATMENT OUTCOME; AMBULATORY CARE; AMBULATORY MONITORING; BLOOD; CHEMICALLY INDUCED DISORDER; DENMARK; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; AMBULATORY CARE; BLOOD GLUCOSE; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INFUSIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT SATISFACTION; QUESTIONNAIRES; YOUNG ADULT;

EID: 84873268192     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nørgaard K. A nationwide study of continuous subcutaneous insulin infusion (CSII) in Denmark. Diabetic Med 2003;20:307-11.
2. Nørgaard K. Anvendelse af insulinpumper I Danmark. Ugeskr Læger 2003;165:2380-2.
3. National Danish Board of Health. Anbefalinger for anvendelse af insulinpumper 2007. Copenhagen: National Danish Board of Health, 2008.
4. Bradley C. The Diabetes Treatment Satisfaction Questionnaire: DTSQ. In Bradley C (Ed) Handbook of Psychology and Diabetes: A guide to psychological measurement in diabetes research and practice. Chur, Switzerland: Harwood Academic Publishers, 1994.
5. Bradley C. The diabetes treatment satisfaction questionnaire (DTSQ): change version for use alongside status version provides appropriate solution where ceiling effects occur. Diab Care 1999;22:530-2.
6. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy-a meta-anlysis. Diab Care 2003;26:1079-87.
7. Nørgaard K, Sohlberg A, Godall G. Cost-effectiveness of continueous subcutaneous insulin infusion therapy for type 1 diabetes. Ugeskr læger 2010;172:2020-5.
8. Arbejdsgruppe under Dansk endokrinologisk Selskab og Dansk Pædiatrisk selskab. Kontinuerlig glukose monitorering. 2011. www.endocrinology/dk/ index.php/des2-4/links/Klaringsrapport-2011. (15 Sep 2011).
9. Nørgaard K, Scaramuzza AE, Bratina N et al. Diabetologia 2011;54 (Suppl 1), A 974.
10. Pedersen-Bjergaard U, Pramming S, Heller SR et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004;20:479-86.
11. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diab Med 2008;25:765-74.
12. Olsen BS, Johannesen J. Insulinpumpe til børn med type 1-diabetes. Ugeskr Læger 2007;169:1101.
13. Nicolucci A, Maione A, Amoretti R et al. Quality of life and treatment satisfaction in adults with type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diab Med 2008;25:213-20.
14. Schuffham P, Carr L. The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes. Diab Med 2003;20:586-93.
15. Linkeschova R, Raoul M, Bott U et al. Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diab Med 2002;19:746-51.